Last Week Fitbit, Inc. (NYSE:FIT) Ratings

Investment analysts at William Blair cut their Q4 2018 earnings per share (EPS) estimates for Fitbit in a research note issued on Wednesday, October 31st. During the same period in the prior year, the company earned ($0.01) earnings per share. The stock rating was reinitiated by William Blair with "Market Perform" on Wednesday, June 20.

FIT has been the topic of a number of research analyst reports. Stifel Nicolaus increased their price target on shares of Fitbit from $5.50 to $6.00 and gave the stock a "hold" rating in a report on Thursday, August 2nd.

Wedbush "Upgrades" Fitbit Inc (NYSE:FIT) in a research note issued to investors on 10/12/18 to Outperform with price target of $0. The stock rating was maintained by Stifel Nicolaus with "Hold" on Thursday, August 2. MED upgraded shares of Fitbit from a "neutral" rating to an "outperform" rating and set a $6.50 target price for the company in a research note on Friday, October 12th. Finally, ValuEngine raised shares of Fitbit from a "hold" rating to a "buy" rating in a research report on Monday, August 20th. The company now has a consensus rating of "Hold" and a consensus target price of $5.83. Wall Street analysts covering the stock are projecting that the stock will reach $6.5 within the next 52-weeks.

Fitbit Inc (NYSE:FIT)'s trailing twelve month revenues are $1.51 Billion, whereas its price to sales ratio for the same period is 0.97. Fitbit has a 12 month low of $4.23 and a 12 month high of $7.79. (NYSE:FIT), during the last 50 days, its Raw Stochastic average was observed 80.00%, representing a downgrade from this organization's 20-day Raw Stochastic average - which was posted 87.31%. The scientific and technical instruments company reported $0.04 EPS for the quarter, beating the Zacks' consensus estimate of ($0.01) by $0.05. The firm had revenue of $393.60 million for the quarter, compared to analysts' expectations of $381.25 million. The business's revenue for the quarter was up.3% compared to the same quarter past year. During the same period past year, the business earned ($0.01) EPS. Hedge funds and other institutional investors own 62.18% of the company's stock. Xact Kapitalforvaltning AB increased its position in shares of Fitbit by 69.7% during the 1st quarter. Insiders own 19.84% of the company's stock. MetLife Investment Advisors LLC now owns 95,538 shares of the scientific and technical instruments company's stock worth $624,000 after buying an additional 12,109 shares in the last quarter. Russell Investments Group Ltd. boosted its holdings in Fitbit by 11.7% during the first quarter. Rhumbline Advisers now owns 208,891 shares of the scientific and technical instruments company's stock worth $1,364,000 after buying an additional 16,600 shares in the last quarter. Finally, Rhumbline Advisers boosted its holdings in Fitbit by 8.6% during the second quarter. Missan Andy sold 7,500 shares for $169,239 in transaction occurred on 2018/10/10.

Continuing to look at similarly important data, this stock's distance from its 200-day Simple Moving Average, or SMA 200, is 6.76% at the time of writing. Following the sale, the executive vice president now owns 161,881 shares in the company, valued at $961,573.14. The sale was disclosed in a legal filing with the SEC, which is available through this link.

In other news, Director Steven Joseph Murray sold 1,000,000 shares of the stock in a transaction dated Monday, August 27th. After making this transaction, the EVP, General Counsel, Sect. owns a direct stake of 35,700 shares, worth $1,032,358, as per the last closing price. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 1,025,000 shares of company stock worth $6,354,550.

Fitbit, Inc, a technology company, provides health solutions in the United States and internationally.